PMC:7212949 / 9509-9840 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T39","span":{"begin":40,"end":45},"obj":"Body_part"},{"id":"T40","span":{"begin":128,"end":133},"obj":"Body_part"},{"id":"T41","span":{"begin":193,"end":197},"obj":"Body_part"}],"attributes":[{"id":"A39","pred":"fma_id","subj":"T39","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A40","pred":"fma_id","subj":"T40","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A41","pred":"fma_id","subj":"T41","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"Key findings on investigations Abnormal chest CT (100%); (98% bilateral) • ↓PaO2\n• ↓PaO2:FiO2 • Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease CT: Patchy bilateral ground glass opacities"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T35","span":{"begin":40,"end":45},"obj":"Body_part"},{"id":"T36","span":{"begin":128,"end":133},"obj":"Body_part"},{"id":"T37","span":{"begin":193,"end":197},"obj":"Body_part"}],"attributes":[{"id":"A35","pred":"uberon_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A36","pred":"uberon_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A37","pred":"uberon_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Key findings on investigations Abnormal chest CT (100%); (98% bilateral) • ↓PaO2\n• ↓PaO2:FiO2 • Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease CT: Patchy bilateral ground glass opacities"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57","span":{"begin":40,"end":45},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T58","span":{"begin":128,"end":133},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T59","span":{"begin":193,"end":197},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T60","span":{"begin":193,"end":197},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"Key findings on investigations Abnormal chest CT (100%); (98% bilateral) • ↓PaO2\n• ↓PaO2:FiO2 • Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease CT: Patchy bilateral ground glass opacities"}

{"project":"LitCovid-sentences","denotations":[{"id":"T158","span":{"begin":0,"end":80},"obj":"Sentence"},{"id":"T159","span":{"begin":81,"end":116},"obj":"Sentence"},{"id":"T160","span":{"begin":117,"end":144},"obj":"Sentence"},{"id":"T161","span":{"begin":145,"end":187},"obj":"Sentence"},{"id":"T162","span":{"begin":188,"end":291},"obj":"Sentence"},{"id":"T163","span":{"begin":292,"end":331},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Key findings on investigations Abnormal chest CT (100%); (98% bilateral) • ↓PaO2\n• ↓PaO2:FiO2 • Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease CT: Patchy bilateral ground glass opacities"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1672","span":{"begin":10,"end":15},"obj":"GO:0007565"},{"id":"T1673","span":{"begin":36,"end":37},"obj":"GO:0007596"},{"id":"T1676","span":{"begin":233,"end":235},"obj":"GO:0016265"},{"id":"T1677","span":{"begin":252,"end":255},"obj":"UBERON:0001987"},{"id":"T121","span":{"begin":40,"end":45},"obj":"UBERON:0001443"},{"id":"T122","span":{"begin":193,"end":197},"obj":"UBERON:0002048"},{"id":"T571","span":{"begin":90,"end":95},"obj":"UBERON:0002107"},{"id":"T572","span":{"begin":125,"end":133},"obj":"SP_7"},{"id":"T573","span":{"begin":166,"end":180},"obj":"CL:1000488"},{"id":"T574","span":{"begin":192,"end":199},"obj":"UBERON:0002294"},{"id":"T575","span":{"begin":200,"end":209},"obj":"UBERON:0000483"},{"id":"T576","span":{"begin":236,"end":246},"obj":"GO:0010467"},{"id":"T577","span":{"begin":250,"end":254},"obj":"G_3;PG_10;PR:000003622"},{"id":"T578","span":{"begin":308,"end":315},"obj":"GO:0008152"},{"id":"T579","span":{"begin":322,"end":327},"obj":"UBERON:0002107"}],"text":"Key findings on investigations Abnormal chest CT (100%); (98% bilateral) • ↓PaO2\n• ↓PaO2:FiO2 • Abnormal CXR (59.1%)\n• Abnormal Chest CT (86.2%)\n• Ground glass opacity most common (56.4%)\n• No lung imaging findings in 17.9% patients with nonsevere disease and in 2.9% with severe disease CT: Patchy bilateral ground glass opacities"}